Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / SHS USD
-
Number of holders
-
427
-
Total 13F shares, excl. options
-
56,377,626
-
Shares change
-
-911,863
-
Total reported value, excl. options
-
$8,780,138,605
-
Value change
-
-$114,026,201
-
Put/Call ratio
-
67%
-
Number of buys
-
200
-
Number of sells
-
196
-
Price
-
$155.67
Institutional Holders of Jazz Pharmaceuticals plc - SHS USD (JAZZ) as of Q1 2022
As of 31 Mar 2022 Jazz Pharmaceuticals plc - SHS USD (JAZZ) had 427 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 56,377,626 shares of stock of the company.
Largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, JPMORGAN CHASE & CO, WELLINGTON MANAGEMENT GROUP LLP, STATE STREET CORP, LSV ASSET MANAGEMENT, FMR LLC, RENAISSANCE TECHNOLOGIES LLC, Polaris Capital Management, LLC, and CANADA PENSION PLAN INVESTMENT BOARD.
This table shows 433 institutional shareholders of the security as of 31 Mar 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.